Phase II trial of dolastatin-10 in patients with advanced breast cancer

Author: Perez Edith   Hillman David   Fishkin Paul   Krook James   Tan Winston   Kuriakose Phillip   Alberts Steven   Dakhil Shaker  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.23, Iss.3, 2005-06, pp. : 257-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content